Fig. 7: Nanoparticle tumor-targeted delivery of ZHX2-siRNA attenuates DLBCL progress. | Leukemia

Fig. 7: Nanoparticle tumor-targeted delivery of ZHX2-siRNA attenuates DLBCL progress.

From: Liquid-liquid phase separation of ZHX2 protects DLBCL cells against ferroptosis through induction of SLC3A2

Fig. 7

A Schematic of the preparation process of ZHX2-siRNA@LNP. B For the SU-DHL-4 xenograft models, the load and distribution of LNP in tumors and organs were photographed with an IVIS (n = 4 in each group). C Representative HE and Ki-67 images of tumors from SU-DHL-4 cell xenograft models, including the PBS, ZHX2-siCtrl@LNP, and ZHX2-siRNA@LNP groups. For (C), scale bar, 50 μm. Data are mean ± SD values.

Back to article page